| Introduction to nanocoatings produced by layer-by-layer (LbL) self-assembly MM De Villiers, DP Otto, SJ Strydom, YM Lvov Advanced drug delivery reviews 63 (9), 701-715, 2011 | 475 | 2011 |
| Nano-encapsulation of furosemide microcrystals for controlled drug release H Ai, SA Jones, MM de Villiers, YM Lvov Journal of controlled release 86 (1), 59-68, 2003 | 331 | 2003 |
| The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine B Devarakonda, RA Hill, MM de Villiers International journal of pharmaceutics 284 (1-2), 133-140, 2004 | 296 | 2004 |
| The application of halloysite tubule nanoclay in drug delivery YM Lvov, MM DeVilliers, RF Fakhrullin Expert opinion on drug delivery 13 (7), 977-986, 2016 | 292 | 2016 |
| Nanotechnology in drug delivery MM De Villiers, P Aramwit, GS Kwon Springer Science & Business Media, 2009 | 280 | 2009 |
| Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins B Devarakonda, RA Hill, W Liebenberg, M Brits, MM de Villiers International journal of pharmaceutics 304 (1-2), 193-209, 2005 | 216 | 2005 |
| Inhibiting surface crystallization of amorphous indomethacin by nanocoating T Wu, Y Sun, N Li, MM de Villiers, L Yu Langmuir 23 (9), 5148-5153, 2007 | 189 | 2007 |
| Encapsulation of drug nanoparticles in self-assembled macromolecular nanoshells AS Zahr, M de Villiers, MV Pishko Langmuir 21 (1), 403-410, 2005 | 173 | 2005 |
| Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes B Devarakonda, DP Otto, A Judefeind, RA Hill, MM de Villiers International journal of pharmaceutics 345 (1-2), 142-153, 2007 | 160 | 2007 |
| Intensive short course chemotherapy in the management of tuberculous meningitis PR Donald, JF Schoeman, LE Van Zyl, M Pretorius, JM De Villiers, ... The international journal of tuberculosis and lung disease 2 (9), 704-711, 1998 | 148 | 1998 |
| Controlled release of dexamethasone from microcapsules produced by polyelectrolyte layer-by-layer nanoassembly N Pargaonkar, YM Lvov, N Li, JH Steenekamp, MM de Villiers Pharmaceutical research 22, 826-835, 2005 | 146 | 2005 |
| Theory and practice of contemporary pharmaceutics TK Ghosh, BR Jasti, M De Villiers, W Kolling CRC press, 2021 | 139 | 2021 |
| The solubilization of the poorly water soluble drug nifedipine by water soluble 4-sulphonic calix [n] arenes W Yang, MM de Villiers European journal of pharmaceutics and biopharmaceutics 58 (3), 629-636, 2004 | 135 | 2004 |
| Preparation and physicochemical characterization of 5 niclosamide solvates and 1 hemisolvate EC Van Tonder, MD Mahlatji, SF Malan, W Liebenberg, MR Caira, ... AAPS Pharmscitech 5, 86-95, 2004 | 132 | 2004 |
| Encyclopedia of chromatography - Chromatographic analysis of anti tuberculosis drugs. J Cazes, MM De Villiers CRC press, 2009 | 130 | 2009 |
| Paclitaxel encapsulated in halloysite clay nanotubes for intestinal and intracellular delivery R Yendluri, Y Lvov, MM de Villiers, V Vinokurov, E Naumenko, ... Journal of Pharmaceutical Sciences 106 (10), 3131-3139, 2017 | 129 | 2017 |
| Effect of 4-sulphonato-calix [n] arenes and cyclodextrins on the solubilization of niclosamide, a poorly water soluble anthelmintic W Yang, MM de Villiers The AAPS journal 7, E241-E248, 2005 | 123 | 2005 |
| Application of halloysite clay nanotubes as a pharmaceutical excipient R Yendluri, DP Otto, MM De Villiers, V Vinokurov, YM Lvov International journal of pharmaceutics 521 (1-2), 267-273, 2017 | 122 | 2017 |
| The filtration activity of a serpulid polychaete population (Ficopomatus enigmaticus (Fauvel) and its effects on water quality in a coastal marina BR Davies, V Stuart, M De Villiers Estuarine, Coastal and Shelf Science 29 (6), 613-620, 1989 | 116 | 1989 |
| Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs E Swanepoel, W Liebenberg, MM de Villiers European journal of pharmaceutics and biopharmaceutics 55 (3), 345-349, 2003 | 113 | 2003 |
